T

TYK Medicines
2410

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
HK$7.69B
EV
HK$7.40B
Shares Outstanding
370.84M
Beta
-

Wall Street View

Analyst Rating
BUY
Analyst Target Price
HK$29.15
P/E 2023E
-
P/Revenue 2023E
-

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About TYK Medicines, Inc

gainify

T

TYK Medicines, Inc

2410

TYK Medicines, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, acquisition, development, and commercialization of therapies to address unmet medical needs in cancer treatment. Its lead product candidate is TY-9591, a third-generation epider...

Sector

Industry

CEO

Wu, Yusheng

Employees

153

IPO Date

Headquarters

Tower A, Changxing World Trade Building, Room 1403-2, Floor 14, No. 1278 Mingzhu Road, Changxing Economic Development Zone, Huzhou, Zhejiang Province China

gainify
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on Trustpilot
powered-by-sp

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2025, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2025 Gainify. All rights reserved.